# Insulet Corp: Form 10-K for the period ended Dec 31, 2013

- Company: [Insulet Corp](/companies/podd.md) (CIK 1145197)
- Form: 10-K
- Filed: 2014-02-28
- Accepted by EDGAR: Feb 27, 2014, 22:44 ET
- Period: 2013-12-31
- Accession: 0001145197-14-000013
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1145197/000114519714000013/podd_20131231x10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1145197/000114519714000013/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-10-01 to 2013-12-31 | $68.5m | us-gaap:SalesRevenueNet |
| Revenue | 12 months, 2013-01-01 to 2013-12-31 | $247.1m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months, 2013-01-01 to 2013-12-31 | $134.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2013-10-01 to 2013-12-31 | $33.0m | us-gaap:GrossProfit |
| Gross profit | 12 months, 2013-01-01 to 2013-12-31 | $112.4m | us-gaap:GrossProfit |
| Research and development | 12 months, 2013-01-01 to 2013-12-31 | $21.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2013-01-01 to 2013-12-31 | −$29.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2013-01-01 to 2013-12-31 | $100.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-10-01 to 2013-12-31 | −$2.5m | us-gaap:NetIncomeLoss |
| Net income | 12 months, 2013-01-01 to 2013-12-31 | −$45.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-10-01 to 2013-12-31 | −$0.04 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 12 months, 2013-01-01 to 2013-12-31 | −$0.83 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months, 2013-01-01 to 2013-12-31 | $3.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2013-01-01 to 2013-12-31 | $7.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2013-12-31 | $149.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-12-31 | $198.2m | us-gaap:AssetsCurrent |
| Total assets | at 2013-12-31 | $288.0m | us-gaap:Assets |
| Current liabilities | at 2013-12-31 | $42.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-12-31 | $163.4m | us-gaap:Liabilities |
| Long-term debt | at 2013-12-31 | $113.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2013-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2013-12-31 | $124.6m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1145197/000114519714000013/podd_20131231x10k.htm

Filed Feb 28, 2014.
Source: SEC EDGAR, the filing index for accession 0001145197-14-000013. Last ingested by Listed: Nov 14, 2026, 12:01 ET. No prices; not investment advice.
